Cellular and molecular aspects of monoamine neurotransmitter transporters

Japanese Journal of Pharmacology
S Kitayama, T Dohi

Abstract

Neurotransmitter transporters terminate synaptic neurotransmission by accumulating neurotransmitters once again after release in a sodium- and chloride-dependent fashion. The availability of the cloned neurotransmitter transporters has allowed investigation into the roles of these transporters in neuronal function. Molecular biological and protein engineering studies including in vitro site-directed mutagenesis, chimera formation of several transporter clones, or epitope-tagging various regions of transporter proteins, have revealed the topology and functionally mapped the transporter proteins. Monoamine neurotransmitter transporters such as those for dopamine, norepinephrine and serotonin are of interest, since they are a target of drugs of abuse and are involved in neuronal disorders including Parkinson's disease and depression. Therefore, elucidating the molecular basis of these transporters may clarify these problems and help develop treatments with which to combat these disorders and drug abuse.

References

Oct 26, 1979·European Journal of Pharmacology·R W HortonB S Meldrum
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T StorckW Stoffel
May 1, 1992·Brain Research. Molecular Brain Research·S ShimadaG Uhl
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J GuastellaN Davidson
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y Stern-BachS Schuldiner
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D EricksonB J Hoffman
Nov 17, 1992·Biochimica Et Biophysica Acta·G M Anderson, W C Horne
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Q R LiuN Nelson
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S KitayamaG R Uhl
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S UchidaJ S Handler
Jun 29, 1992·FEBS Letters·Q R LiuN Nelson
Jul 1, 1991·Trends in Neurosciences·M J KuharJ W Boja
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T B UsdinB J Hoffman
Oct 25, 1991·Science·B J HoffmanM J Brownstein
Sep 14, 1990·Science·J GuastellaB I Kanner
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R P Malchow, H Ripps
May 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C D StraderR A Dixon
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C D StraderR A Dixon
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Z Langer, H Schoemaker
Aug 21, 1995·The Journal of Comparative Neurology·C FreedM J Kuhar
Oct 1, 1993·Trends in Neurosciences·G Levi, M Raiteri

❮ Previous
Next ❯

Citations

Sep 12, 2009·Journal of Clinical Psychopharmacology·Janette McGaughAlison Oliveto
Oct 1, 2011·Analytical and Bioanalytical Chemistry·Janina Witowska-JaroszMaciej Jarosz
Dec 18, 2001·Brain Research. Molecular Brain Research·F A Paczkowski, L J Bryan-Lluka
May 23, 1998·Annual Review of Pharmacology and Toxicology·L ZhangK M Giacomini
Feb 3, 1999·Annual Review of Genetics·J W Jarvik, C A Telmer
Jan 5, 2005·Biochemical and Biophysical Research Communications·Tetsurou IkedaNobuyuki Nukina
Nov 21, 2015·Brain Imaging and Behavior·Emi YamanoYasuyoshi Watanabe
Dec 1, 2009·Journal of Pharmacological Sciences·Mariko NobukuniNorio Sakai
Apr 28, 2009·Pharmacology & Therapeutics·Toshihiro DohiNorimitsu Morioka
Jul 3, 2003·The Journal of Biological Chemistry·Lesley J Bryan-LlukaRichard J Lewis
Oct 12, 2005·Journal of Pharmacological Sciences·Shigeo Kitayama, Chiharu Sogawa
Jan 25, 2008·The Cleft Palate-craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association·Yuichiro HataHiroyuki Ishikawa
Apr 10, 1999·The Journal of Biological Chemistry·S KitayamaT Dohi
Dec 10, 1999·Epilepsy Research·D P Figlewicz
Nov 13, 2003·European Journal of Pharmacology·Shigeo Kitayama, Toshihiro Dohi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.